Skip to content
Recall Observatory FDA recall evidence

Drug product

LEUKINE (Sargramostim) for Injection, 250 mcg/ vial, 5mL vials, 5 (250 mcg vials) per box, Rx only, Mfd by Partner Therapeutics, Inc. Lexington, MA 02421, NDC 71837-5843-5

D-0655-2021

June 23, 2021

Class III

Product summary

Firm
Partner Therapeutics Inc
Event
Event 88164
Status
Terminated
Classification
Class III
Quantity
32,260 vials
Official record key
drug-enforcement:D-0655-2021

Official wording

Reason: FAILED STABILITY SPECIFICATION: Out-of-specification (OOS) result observed for Leukine (sargramostim) at the 27-month stability timepoint.

Code information: Lot #: E8023E, exp. date 11/30/2022

Distribution pattern: Product was distributed to one government account (ASPR)

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Out-of-specification